Video

Q&A With Robert Eckel From the University of Colorado: Major Medical Organizations Largely Agree on New Cholesterol Guidelines

Author(s):

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

With new medications and therapies being developed for a variety of conditions, a consistent message from the medical community can help move treatment forward.

Robert Eckel, MD, from the University of Colorado Anschutz Medical Campus discussed new guidelines that have been adopted by the American Heart Association, the American College of Cardiology, and the American Diabetes Assocation during the latter's 75th Annual Scientific Sessions in Boston. While there are only some minor disagreements, Eckel said one major difference is whether a risk management program could help patients monitor their health.

Related Videos
Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD
Transformations in Aortic Disease Management with Mehrdad Ghoreishi, MD | Image Credit: Baptist Health South Florida
Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
© 2025 MJH Life Sciences

All rights reserved.